Brandon Capital — 2023 Investments

1 investments dated 2023 · listed companies and verified rows first · show all

AstronauTX Ltdastronautx.bio inSeries A · Oct 2023 · $59M

AstronauTx is a biotechnology company focused on drug discovery and development for neurodegenerative and neuroinflammatory diseases, working across small molecules and biologics.

BiotechDeep TechHealthtechLongevityMedical Devices

Jane Rhodes(Chief Executive Officer)inMagnus Ivarsson(Chief Scientific Officer)inHannah Pearce(Chief Operating Officer)inMichelle L. Mellion(Chief Medical Officer)in

PartnerJonathan Tobin· solo GP

Co-investorsDementia Discovery Fund MPM BioImpact Novartis Venture Fund SV Health Investors UCL Technology Fund AlbionVC

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.